Clinical Trial Update: Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluating darbepoetin alfa for treating anemia in patients with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Kidney Disease | Phase 3 | Status: COMPLETED